The next issue will be published on August 28, 2021.   A Cell Press partner journal
See the unseen. Change the unchanged.
The Innovation í¬ published by Cell Press in partnership with members of the Youth
Innovation Promotion Association (YIPA),a part of the Chinese Academy of
Sciencesí¬is a new broad-scope, open access journal publishing basic and applied
research that has impact for the benefit of society.
On the cover: Cancer is a complicated disease by genetic mutations. Loads of scientists and doctors had been making history to cancer research and clinical management. Now we're in the era of precision medicine and it is possible to conquest cancers via multidisciplinary collaboration in the near future.
  Related comments
í˝ Touristú║anonymous   [11-19]
55% of liver cancer cases in the world come from China.
Add comment (English only)
Name*:  
E-mail:  
Telephone:  
Code:    
Comments*:
Position: Home > issue > The 2nd Issue (August 28, 2020)
Therapy of primary liver cancer
Category:   Review   Download:  PDF  Figure
Author: Mei Feng, Yisheng Pan, Ruirui Kong, Shaokun Shu

821_5.jpg

Therapy of primary liver cancer


Primary liver cancer (PLC) is a fatal disease that affects millions of lives worldwide. PLC is the leading cause of cancer-related deaths and the rate of incidence is predicted to rise in the coming decades. PLC can be categorized into three major histological subtypes: hepatocellular carcinoma (HCC), intrahepatic cholangiocarcinoma (ICC), and combined HCC-ICC (cHCC-ICC). These subtypes are distinct with respect to epidemiology, clinicopathological features, genetic alterations, and clinical managements, which are thoroughly summarized in this review. The state of treatment strategies for each subtype, including the currently approved drugs and the potential novel therapies, are also discussed.


Cite this article

Feng, M., Pan, Y., Kong, R. and Shu, S. Therapy of Primary Liver Cancer. The Innovation 1 (2), 100032 (2020). doi: 10.1016/j.xinn.2020.100032





Host
Publishing partner
Journal links
Academic co-partner
  SHANGHAI INSTITUTE OF APPLIED PHYSICS, CAS
  INSTITUTE OF MICROBIOLOGY, CAS
  XI'AN INSTITUTE OF OPTICS AND PRECISION MECHANICS, CAS
Stay connected

  office@the-innovation.org
  the.innovation.journal
  the.innovation.journal
  The_InnovationJ
  TheInnovation┤┤đ┬
  TheInnovation┤┤đ┬
  The Innovation
  The_Innovation

  Copyright © 2019-2021 Youth Innovation All Rights Reserved